title: Very Late Stent Thrombosis: The Value of Optical Coherence Tomography in Defining Etiology and Guiding Treatment.
authors.affiliation: Liverpool Heart and Chest Hospital, NHS Foundation Trust, Liverpool, United Kingdom; University Hospital Aintree, NHS Foundation Trust, Liverpool, United Kingdom. Electronic address: liammullen@nhs.net.
authors.forename: Liam
authors.initials: L
authors.lastname: Mullen
authors.affiliation: Liverpool Heart and Chest Hospital, NHS Foundation Trust, Liverpool, United Kingdom; University Hospital Aintree, NHS Foundation Trust, Liverpool, United Kingdom; University of Liverpool, Liverpool, United Kingdom.
authors.forename: Aleem
authors.initials: A
authors.lastname: Khand
mesh_terms: D000077284:Abciximab; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D023903:Coronary Restenosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D003328:Coronary Thrombosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D003331:Coronary Vessels / Q000000981:diagnostic imaging*; D054855:Drug-Eluting Stents / Q000009:adverse effects; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000008:administration & dosage*; D007269:Injections, Intra-Arterial / Q000379:methods; D000069451:Long Term Adverse Effects / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D000072658:Non-ST Elevated Myocardial Infarction / Q000601:surgery*; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D041623:Tomography, Optical Coherence / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D000077284:Abciximab